Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 14

Results For "LA"

10659 News Found

Redcliffe Labs appoints Vijay T. S. as Chief People Officer
People | June 01, 2026

Redcliffe Labs appoints Vijay T. S. as Chief People Officer

Vijay brings more than 28 years of experience across healthcare, technology, edtech, manufacturing, and global business environments


Clariant bags FDA nod for bio-based PVC additives
R&D | June 01, 2026

Clariant bags FDA nod for bio-based PVC additives

Derived from rice bran wax, Licocare RBW products offer a renewable solution with a substantially lower carbon footprint than conventional montan waxes


MediElaj raises $100K to set up AI-powered healthcare kiosks in underserved regions
Medical Device | June 01, 2026

MediElaj raises $100K to set up AI-powered healthcare kiosks in underserved regions

The company is building a connected healthcare ecosystem that utilises smart healthcare kiosk and mobile app to deliver at-home, AI-assisted health screenings and non-invasive health measurements


Pantherna acquisition to boost T-CURX’s clinical translation of non-viral In Vivo CAR-T strategies
Healthcare | June 01, 2026

Pantherna acquisition to boost T-CURX’s clinical translation of non-viral In Vivo CAR-T strategies

Proprietary technologies in LNP-based delivery of mRNA and DNA vectors to advance T-CURX innovative in vivo CAR-T assets into clinical trials one year earlier


Indoco's formulation plant at Baddi receives EU GMP certification
News | June 01, 2026

Indoco's formulation plant at Baddi receives EU GMP certification

This certification confirms that the facility complies with Good Manufacturing Practice requirements as referred in the EC Directive


AbbVie bags major European label expansion for VENCLYXTO in chronic lymphocytic leukemia
Clinical Trials | May 31, 2026

AbbVie bags major European label expansion for VENCLYXTO in chronic lymphocytic leukemia

The expanded indication is backed by data from the Phase 3 AMPLIFY and GLOW trials and the Phase 2 CAPTIVATE study,


AstraZeneca reports mixed Phase III results for anselamimab in rare cardiac amyloidosis trial
Clinical Trials | May 30, 2026

AstraZeneca reports mixed Phase III results for anselamimab in rare cardiac amyloidosis trial

The programme evaluated anselamimab as a first-line add-on to standard plasma cell dyscrasia therapy in patients with advanced cardiac AL amyloidosis


Pfizer's LORBRENA delivers landmark seven-year survival results in advanced lung cancer trial
Clinical Trials | May 30, 2026

Pfizer's LORBRENA delivers landmark seven-year survival results in advanced lung cancer trial

The findings mark one of the longest progression-free survival outcomes ever reported in advanced lung cancer


FDA greenlights AstraZeneca’s Imfinzi combo in bladder cancer breakthrough
R&D | May 30, 2026

FDA greenlights AstraZeneca’s Imfinzi combo in bladder cancer breakthrough

The study tracked patients for more than five years (median 60.7 months), with protection against disease returning emerging in under four months and continuing long term


FDA delays AstraZeneca decision on camizestrant as regulators seek more data
Drug Approval | May 30, 2026

FDA delays AstraZeneca decision on camizestrant as regulators seek more data

The filing is backed by results from the pivotal SERENA-6 Phase III trial